Articles with public access mandates - Du Pasquier R.Learn more
Not available anywhere: 12
Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity
J Kuhle, C Barro, G Disanto, A Mathias, C Soneson, G Bonnier, Ö Yaldizli, ...
Multiple Sclerosis Journal 22 (12), 1550-1559, 2016
Mandates: Swiss National Science Foundation
Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?
C Antoniol, S Jilek, M Schluep, N Mercier, M Canales, G Le Goff, ...
Neurology 79 (23), 2258-2264, 2012
Mandates: Swiss National Science Foundation
Increased ex vivo antigen presentation profile of B cells in multiple sclerosis
A Mathias, G Perriard, M Canales, C Soneson, M Delorenzi, M Schluep, ...
Multiple Sclerosis Journal 23 (6), 802-809, 2017
Mandates: Swiss National Science Foundation
Demyelination as a complication of new immunomodulatory treatments
AP Lysandropoulos, RA Du Pasquier
Current opinion in neurology 23 (3), 226-233, 2010
Mandates: Swiss National Science Foundation
Natalizumab treatment alters the expression of T-cell trafficking marker LFA-1 α-chain (CD11a) in MS patients
S Jilek, A Mathias, M Canales, A Lysandropoulos, G Pantaleo, M Schluep, ...
Multiple Sclerosis Journal 20 (7), 837-842, 2014
Mandates: Swiss National Science Foundation
Neurofilament light chain elevation and disability progression in multiple sclerosis
A Abdelhak, P Benkert, S Schaedelin, WJ Boscardin, C Cordano, ...
JAMA neurology 80 (12), 1317-1325, 2023
Mandates: Swiss National Science Foundation
Severe post-EBV encephalopathy associated with myelin oligodendrocyte glycoprotein-specific immune response
S Jilek, J Kuhle, P Meylan, MD Reichhart, G Pantaleo, RA Du Pasquier
Journal of neuroimmunology 192 (1-2), 192-197, 2007
Mandates: Swiss National Science Foundation
Delayed and recurrent dimethyl fumarate induced-lymphopenia in patients with multiple sclerosis
S Borrelli, A Mathias, G Le Goff, R Du Pasquier, M Théaudin, C Pot
Multiple Sclerosis and Related Disorders 63, 103887, 2022
Mandates: Swiss National Science Foundation
Progressive multifocal leukoencephalopathy in two natalizumab-treated stepsisters: an intriguing coincidence
F Bacchetta, A Mathias, M Schluep, R Du Pasquier
Multiple Sclerosis Journal 23 (2), 300-303, 2017
Mandates: Swiss National Science Foundation
Minimal supportive treatment in natalizumab-related PML in a MS patient
PH Lalive, C Bridel, RI Ferfoglia, L Kaiser, R Du Pasquier, F Barkhof, ...
Journal of Neurology, Neurosurgery & Psychiatry 86 (3), 354-355, 2015
Mandates: Swiss National Science Foundation
The association between depressive symptoms and neurocognitive impairment in people with well-treated HIV in Switzerland
G Santos, I Locatelli, M Métral, A Berney, I Nadin, A Calmy, P Tarr, ...
International journal of STD & AIDS 32 (8), 729-739, 2021
Mandates: Swiss National Science Foundation
Posterior spinal cord infarctions due to neurosyphilis
O Bill, RA Du Pasquier, P Michel
Neurology: Clinical Practice 4 (6), 538-540, 2014
Mandates: Swiss National Science Foundation
Available somewhere: 90
Type I interferon inhibits interleukin-1 production and inflammasome activation
G Guarda, M Braun, F Staehli, A Tardivel, C Mattmann, I Förster, M Farlik, ...
Immunity 34 (2), 213-223, 2011
Mandates: Swiss National Science Foundation
Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis
G Disanto, C Barro, P Benkert, Y Naegelin, S Schädelin, A Giardiello, ...
Annals of neurology 81 (6), 857-870, 2017
Mandates: Swiss National Science Foundation
Cognitive dysfunction in HIV patients despite long-standing suppression of viremia
S Simioni, M Cavassini, JM Annoni, AR Abraham, I Bourquin, V Schiffer, ...
Aids 24 (9), 1243-1250, 2010
Mandates: Swiss National Science Foundation
Elevated Tribbles homolog 2–specific antibody levels in narcolepsy patients
V Cvetkovic-Lopes, L Bayer, S Dorsaz, S Maret, S Pradervand, ...
The Journal of clinical investigation 120 (3), 713-719, 2010
Mandates: Swiss National Science Foundation
Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study
P Benkert, S Meier, S Schaedelin, A Manouchehrinia, Ö Yaldizli, ...
The Lancet Neurology 21 (3), 246-257, 2022
Mandates: Swiss National Science Foundation, UK Medical Research Council, European …
Two patients with acute meningoencephalitis concomitant with SARS‐CoV‐2 infection
R Bernard‐Valnet, B Pizzarotti, A Anichini, Y Demars, E Russo, ...
European journal of neurology 27 (9), e43, 2020
Mandates: Swiss National Science Foundation
Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis
S Jilek, M Schluep, P Meylan, F Vingerhoets, L Guignard, A Monney, ...
Brain 131 (7), 1712-1721, 2008
Mandates: Swiss National Science Foundation
Human induced pluripotent stem cell-derived astrocytes are differentially activated by multiple sclerosis-associated cytokines
S Perriot, A Mathias, G Perriard, M Canales, N Jonkmans, N Merienne, ...
Stem cell reports 11 (5), 1199-1210, 2018
Mandates: Swiss National Science Foundation, US National Institutes of Health …
Publication and funding information is determined automatically by a computer program